| Filed On | Filing |
|---|---|
| 23 Jul 2026 | Form 3: Keenan Greg, Chief Medical Officer |
| 22 Jul 2026 |
Form 3: Song Wenru, EVP, Head of R&D
Holds 3,150 shares of Voting Common Stock |
| 22 Jul 2026 | Form 3: Ros Matthew E, Chief Operating Officer |
| 20 Jul 2026 |
Form 3: Crutcher Patrick J, Director
Holds 518,331 shares of Voting Common Stock |
| 20 Jun 2024 |
Form 3: Lucas Svetlana, Director
No securities owned |
| 02 Nov 2023 |
Form 3: Wiggans Thomas G, Director
No securities owned |
| 26 Sep 2023 |
Form 3: Cross Herb, Chief Financial Officer
No securities owned |
| 20 Jun 2023 |
Form 3: Brun Scott C., Director
No securities owned |
| 13 Jun 2023 |
Form 3: Tucker Edwin Jonathan, Chief Medical Officer
No securities owned |
| 17 Feb 2023 |
Form 3: Kapoor Vishal, Director
No securities owned |
| 03 Feb 2023 |
Form 3: Velan Capital Investment Management Lp, 10% owner and 8 others
Holds 8,385,000 shares of Common Stock, par value $0.0001 per share |
| 11 Aug 2022 |
Form 3: Carlyle Group Inc., 10% owner and 7 others
Holds 5,628,558 shares of Voting Common Stock |
| 21 Mar 2022 |
Form 3: Martell Ron, Director
No securities owned |
| 04 Oct 2021 |
Form 3: Roche Holding Ltd, 10% owner and 1 other
Holds 4,624,606 shares of Voting Common Stock |
| 01 Oct 2021 |
Form 3: Abingworth Llp, 10% owner
Holds 5,628,558 shares of Common Stock |
| 01 Oct 2021 |
Form 3: Emster Kurt Von, Director
Holds 5,628,558 shares of Common Stock |
| 01 Oct 2021 |
Form 3: Klein Lawrence Otto, Director
No securities owned |
| 01 Oct 2021 | Form 3: Heller Kevin N., EVP, Research and Development |
| 01 Oct 2021 |
Form 3: Shizuru Judith Anne, Director
Holds 1,129,512 shares of Voting Common Stock |
| 01 Oct 2021 |
Form 3: Mahal Jeetinder Singh, See remarks
Holds 109,627 shares of Voting Common Stock |
Loading...
